{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T06:12:04Z","timestamp":1774764724103,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijrobp.2021.03.048","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T12:14:41Z","timestamp":1617797681000},"page":"1295-1305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis"],"prefix":"10.1016","volume":"110","author":[{"given":"Sarwat","family":"Naz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Leiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajani","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Preston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia L.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Gohain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Gamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Askale","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carter","family":"Van Waes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.03.048_bib0001","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/24550","article-title":"Hsp90 as a capacitor for morphological evolution","volume":"396","author":"Rutherford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0002","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1073\/pnas.1203326109","article-title":"BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2\/M checkpoint activation","volume":"109","author":"Stecklein","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0003","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-08-0505","article-title":"Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0004","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10637-015-0255-1","article-title":"Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors","volume":"33","author":"Do","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10637-010-9493-4","article-title":"A phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma","volume":"30","author":"Pacey","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10637-014-0095-4","article-title":"The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer","volume":"32","author":"He","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0007","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-717X-8-42","article-title":"Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990","volume":"8","author":"Milanovic","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0008","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1349-7006.2011.02191.x","article-title":"The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancer","volume":"103","author":"Graham","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0009","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1158\/1078-0432.CCR-16-3151","article-title":"Efficacy of onalespib, a long-acting second-generation hsp90 inhibitor, as a single agent and in combination with temozolomide against malignant gliomas","volume":"23","author":"Canella","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.CCR-14-0979","article-title":"First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors","volume":"21","author":"Shapiro","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0011","doi-asserted-by":"crossref","first-page":"35652","DOI":"10.18632\/oncotarget.5363","article-title":"The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells","volume":"6","author":"Spiegelberg","year":"2015","journal-title":"Oncotarget"},{"issue":"15 Pt 1","key":"10.1016\/j.ijrobp.2021.03.048_bib0012","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1158\/1078-0432.CCR-07-0632","article-title":"Inhibition of Hsp90: A multitarget approach to radiosensitization","volume":"13","author":"Camphausen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0013","first-page":"8984","article-title":"Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity","volume":"63","author":"Bisht","year":"2003","journal-title":"Cancer Res."},{"issue":"10 Pt 1","key":"10.1016\/j.ijrobp.2021.03.048_bib0014","first-page":"3749","article-title":"Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin: A multitarget approach to radiosensitization","volume":"9","author":"Russell","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0015","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/1078-0432.CCR-19-3102","article-title":"Low-dose Hsp90 inhibitor selectively radiosensitizes HNSCC and pancreatic xenografts","volume":"26","author":"Mehta","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0016","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1038\/s41598-020-62293-4","article-title":"The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: An in vitro and in vivo approach","volume":"10","author":"Spiegelberg","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0017","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1158\/1078-0432.CCR-17-3575","article-title":"Abemaciclib, a selective CDK4\/6 inhibitor, enhances the radiosensitivity of non-small cell lung cancer in vitro and in vivo","volume":"24","author":"Naz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0018","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1158\/1078-0432.CCR-14-3279","article-title":"Radiation enhancement of head and neck squamous cell carcinoma by the dual PI3K\/mTOR inhibitor PF-05212384","volume":"21","author":"Leiker","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"Pt 12","key":"10.1016\/j.ijrobp.2021.03.048_bib0019","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1242\/jcs.039115","article-title":"Radiation-induced mitotic catastrophe in PARG-deficient cells","volume":"122","author":"Ame","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcell.2020.00041","article-title":"Molecular mechanisms of radiation-induced cancer cell death: A primer","volume":"8","author":"Sia","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0021","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00018-009-8740-3","article-title":"DNA repair in mammalian cells: DNA double-strand break repair: How to fix a broken relationship","volume":"66","author":"Pardo","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0022","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/cancers11050688","article-title":"Ben-Sahra I. Cancer cells tune the signaling pathways to empower de novo synthesis of nucleotides","volume":"11","author":"Villa","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0023","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","article-title":"An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis","volume":"162","author":"Birsoy","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0024","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","article-title":"Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells","volume":"162","author":"Sullivan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0025","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130686","article-title":"Vasculogenesis: A crucial player in the resistance of solid tumours to radiotherapy","volume":"87","author":"Brown","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0026","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0027","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0028","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/ijms20133212","article-title":"Tumor microenvironment as a \"game changer\" in cancer radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0029","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clon.2013.06.009","article-title":"The hallmarks of cancer and the radiation oncologist: Updating the 5Rs of radiobiology","volume":"25","author":"Good","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-019-0238-9","article-title":"Assessing the interactions between radiotherapy and antitumour immunity","volume":"16","author":"Grassberger","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0031","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.18632\/oncotarget.26652","article-title":"Abemaciclib: A multi-functional radiation modifier","volume":"10","author":"Naz","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0032","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2010.03.019","article-title":"Discovery and development of Hsp90 inhibitors: A promising pathway for cancer therapy","volume":"14","author":"Porter","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0033","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.acr.2015.10.001","article-title":"HSP90 and immune modulation in cancer","volume":"129","author":"Graner","year":"2016","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0034","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/j.ejca.2013.06.034","article-title":"The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine\/threonine kinase 38 via Sp1 inhibition","volume":"49","author":"Enomoto","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0035","first-page":"8393","article-title":"Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids","volume":"63","author":"Enmon","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0036","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1593\/tlo.13292","article-title":"HSP90 inhibitor SNX5422\/2112 targets the dysregulated signal and transcription factor network and malignant phenotype of head and neck squamous cell carcinoma","volume":"6","author":"Friedman","year":"2013","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0037","first-page":"1287","article-title":"The HSP90 inhibitor onalespib potentiates 177LuDOTATATE therapy in neuroendocrine tumor cells","volume":"55","author":"Lundsten","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0038","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajpath.2012.09.011","article-title":"Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage in cells undergoing oncogene-induced senescence","volume":"182","author":"Mannava","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0039","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/neuonc\/not149","article-title":"Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats","volume":"16","author":"Liu","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2021.03.048_bib0041","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-07-1104","volume":"13","author":"Lang","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621003102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621003102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:53:20Z","timestamp":1759744400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621003102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0360301621003102"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.048","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}